CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
News and press releases
HCA Healthcare UK Network
Read the latest news stories and press releases from HCA Healthcare UK in London, Birmingham and Manchester.
HCA UK offers amyloid-targeting therapies for the treatment of early-stage Alzheimer's disease
Leading private healthcare provider HCA Healthcare UK has announced that it is offering amyloid-targeting therapies for patients diagnosed with early-stage Alzheimer's disease. The therapies available include lecanemab and donanemab - the first two disease-modifying treatments for Alzheimer’s disease licensed for use in Great Britain.